Related references
Note: Only part of the references are listed.Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Karl Swedberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials
Dengfeng Gao et al.
AMERICAN HEART JOURNAL (2012)
Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the Erythropoietin in Myocardial Infarction Trial
Fabrice Prunier et al.
AMERICAN HEART JOURNAL (2012)
Did Clinical Trials in Which Erythropoietin Failed to Reduce Acute Myocardial Infarct Size Miss a Narrow Therapeutic Window?
Mark I. Talan et al.
PLOS ONE (2012)
Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial
Andrew J. Ludman et al.
HEART (2011)
The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention
Jung-Won Suh et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study
Maurizio Ferrario et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction REVEAL: A Randomized Controlled Trial
Samer S. Najjar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
Dirk J. van Veldhuisen et al.
NATURE REVIEWS CARDIOLOGY (2011)
The unfulfilled promise of erythropoietin in patients with MI
Peter van der Meer et al.
NATURE REVIEWS CARDIOLOGY (2011)
Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction - Randomized Controlled Pilot Trial of EPO/AMI-1 Study
Takuya Ozawa et al.
CIRCULATION JOURNAL (2010)
Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After ST-Elevated Acute Myocardial Infarction (EPOC-AMI) - A Pilot, Randomized, Placebo-Controlled Study
Norimasa Taniguchi et al.
CIRCULATION JOURNAL (2010)
Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention A Randomized, Double-Blind Trial
Ilka Ott et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
A single dose of erythropoietin in ST-elevation myocardial infarction
Adriaan A. Voors et al.
EUROPEAN HEART JOURNAL (2010)
Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?
Lennaert Kleijn et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Hannelore Ehrenreich et al.
STROKE (2009)
Effects of erythropoietin after an acute myocardial infarction: Rationale and study design of a prospective, randomized, clinical trial (HEBE III)
Anne M. Belonje et al.
AMERICAN HEART JOURNAL (2008)
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
Jalal K. Ghali et al.
CIRCULATION (2008)
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
Dirk J. van Veldhuisen et al.
EUROPEAN HEART JOURNAL (2007)
Protective effects of erythropoietin in cardiac ischemia - From bench to bedside
Erik Lipsic et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs
Akio Hirata et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study
Erik Lipsic et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction
P van der Meer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion
E Lipsic et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway
AF Tramontano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
L Calvillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
